Aranesp darbepoetin alfa: Development discontinued

Kyowa said in its 2012 earnings that in September it discontinued development of Aranesp

Read the full 143 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE